Long-term medication persistence in stroke patients treated with intravenous thrombolysis

Maja Stefanovic Budimkic1, Tatjana Pekmezovic2, Ljiljana Beslac-Bumbasirevic3

  • 1Neurology Clinic, Clinical Center of Serbia, Belgrade, Serbia.

Insights

Stroke survivors receiving intravenous thrombolysis (IVT) showed better long-term medication persistence for secondary prevention. Higher medication adherence was linked to better functional outcomes post-stroke.

Area of Science:

  • Neurology
  • Pharmacology
  • Public Health

Background:

  • Long-term medication persistence is crucial for secondary stroke prevention.
  • Data on medication persistence in stroke survivors treated with intravenous thrombolysis (IVT) is limited.
  • Understanding medication adherence post-IVT is vital for optimizing patient outcomes.

Purpose of the Study:

  • To evaluate long-term medication persistence in stroke patients treated with IVT.
  • To compare medication persistence between IVT-treated and non-IVT-treated stroke patients.
  • To identify factors associated with medication persistence after acute ischemic stroke.

Main Methods:

  • Retrospective observational study of 203 IVT-treated and 197 non-IVT-treated acute ischemic stroke patients.
  • Median follow-up period of 3 years (range 1-7 years).
  • Analysis of secondary stroke prevention medications including anti-thrombotics, anti-hypertensives, statins, and hypoglycemics.

Main Results:

  • IVT-treated patients demonstrated significantly higher medication persistence (88.7%) compared to non-IVT-treated patients (69.0%).
  • IVT was an independent predictor of medication persistence (OR=2.93, 95% CI=1.48-5.81).
  • Higher medication persistence correlated with favorable long-term functional outcomes in both IVT and non-IVT groups.

Conclusions:

  • Stroke patients treated with IVT exhibit superior long-term medication persistence.
  • Lower medication persistence is associated with greater post-stroke disability.
  • Improving medication adherence in stroke survivors, particularly those with disabilities, is essential for secondary prevention.
Abstract

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
463
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
651
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.3K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.7K
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
654
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
372